Literature DB >> 6752275

A critical analysis of the T cell hybrid technique.

B B Beezley, N H Ruddle.   

Abstract

The T cell hybridization technique can be used to prepare continuous cell lines which express the antigen specificity and function of T cells within the milieu of a proliferating lymphoma. Technical details for the preparation and maintenance, selection and analysis of T cell hybrids are defined. Techniques for cloning of hybrid cells and production of hybrid-derived tumors are also presented. Parameters influencing the hybridization frequency and the production of functional hybrids are discussed. A variety of T cell subsets, including suppressor cells and delayed-type hypersensitivity effector cells as well as T cells maintained on TCGF, are excellent sources of primary parents for hybridization. When BW 5147 is used as the T lymphomas parent in these experiments, the resulting hybridization frequencies range between 10 and 434 X 10(-7). We have had moderate success using YAC-1; however, additional lines such as L5178Y, BALENTL 5, EL4 BU and S491TB.2 have proved ineffective as sources of T lymphoma parents. The technique of T cell hybridization is evaluation in terms of retention of differentiated functions and the stability and growth characteristics of the resultant hybrids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752275     DOI: 10.1016/0022-1759(82)90001-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Generation of a T-cell hybridoma producing a contrasuppressor factor for contact sensitivity.

Authors:  A M Friedman; W Ptak; E Brewer; D R Green; P A Reuter; P M Flood
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

2.  B cell growth factor activity in supernatants of MRL-lpr/lpr derived T cell hybridomas.

Authors:  U Schauer
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

Review 3.  Phenotypic changes in growth-arrested T cell hybrids: a possible avenue to produce functional T cell hybridoma.

Authors:  Koichi Kubota; Kazuya Iwabuchi
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.